Androgenic alopecia - I-Alopecia Ye-Androgenichttps://en.wikipedia.org/wiki/Pattern_hair_loss
I-Alopecia Ye-Androgenic (Androgenic alopecia) kukulahleka kweenwele okuchaphazela ngokukodwa phezulu nangaphambili kwe-scalp. Kwindlela yokulahleka kweenwele zendoda (MPHL), ukulahleka kweenwele ngokuqhelekileyo kuzibonakalisa njengokuhlehla kweenwele zangaphambili, ukulahleka kweenwele kwi-vertex ye-scalp, okanye indibaniselwano yazo zombini. Ukulahleka kweenwele zefemale-pattern (FPHL) zibonakalisa njengokuqhekeka kweenwele kwi-scalp yonke.

Ukulahleka kweenwele zendoda kubonakala kubangelwa yindibaniselwano yemfuza kunye ne-androgens ejikelezayo, ngakumbi i-dihydrotestosterone (DHT). Unobangela wokulahleka kweenwele kwipateni yabasetyhini uhlala ungacacanga.

Unyango oluqhelekileyo lubandakanya i-minoxidil, i-finasteride, i-dutasteride, okanye utyando lokufakelwa kweenwele. Ukusetyenziswa kwe-finasteride kunye ne-dutasteride kubasetyhini abakhulelweyo kunokubangela iziphene zokuzalwa.

○ Unyango
I-Finasteride kunye ne-dutasteride zisebenza kakhulu kumadoda kunye nabasetyhini be-postmenopausal. Idosi ephantsi ye-minoxydil yomlomo ingasetyenziselwa iimeko ezimbalwa ezikhethiweyo.
#Finasteride
#Dutasteride

○ Unyango ― OTC Amachiza
Kumazwe amaninzi, amalungiselelo e-topical minoxidil ayafumaneka kwi-counter-the-counter. Kukho ezinye izongezo ezithi ziyasebenza ngokuchasene nokulahleka kweenwele, kodwa uninzi alukangqinwa ngokwesayensi ukuba luyasebenza.
#5% minoxidil
☆ Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
  • Male-pattern hair loss
    References Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics 34741573 
    NIH
    Although topical minoxidil, oral finasteride, and low‐level light therapy are the only FDA‐approved therapies to treat AGA, they are just a fraction of the treatment options available, including other oral and topical modalities, hormonal therapies, nutraceuticals, PRP and exosome treatments, and hair transplantation.